Coronary Artery pass Grafts Device Market

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery. A normal coronary artery transports blood to and from the heart muscle itself, not through the main circulatory system.

Coronary Artery pass Grafts Device Market contains market size and forecasts of Coronary Artery Bypass Grafts Device in global, including the following market information:

Global Coronary Artery Bypass Grafts Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Coronary Artery Bypass Grafts Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Coronary Artery Bypass Grafts Device companies in 2021 (%)

The global Coronary Artery Bypass Grafts Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Saphenous Vein Grafts Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Coronary Artery Bypass Grafts Device include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical and Karl Storz GmbH. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Coronary Artery Bypass Grafts Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Coronary Artery Bypass Grafts Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Artery Bypass Grafts Device Market Segment Percentages, by Type, 2021 (%)

Saphenous Vein Grafts

Internal Thoracic Artery Grafts

Other

Global Coronary Artery Bypass Grafts Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Artery Bypass Grafts Device Market Segment Percentages, by Application, 2021 (%)

Traditional CABG

Nontraditional CABG

Global Coronary Artery Bypass Grafts Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Artery Bypass Grafts Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Coronary Artery Bypass Grafts Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Coronary Artery Bypass Grafts Device revenues share in global market, 2021 (%)

Key companies Coronary Artery Bypass Grafts Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Coronary Artery Bypass Grafts Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Getinge Group

LivaNova

Terumo

Boston Scientific

Stryker

Edwards Lifesciences

Genesee Biomedical

Karl Storz GmbH